论文部分内容阅读
目的:观察代谢综合征患者心脏结构及心功能改变。方法:332例代谢综合征患者依据体质量指数分为非肥胖组37例,肥胖组295例;肥胖组再依据合并症情况分为4组,A组108例为同时患高血压、高血脂、糖尿病者,B组106例为同时患高血压、高血脂者,C组47例为同时患高血脂、糖尿病者;D组34例为同时患糖尿病、高血压者。患者均行超声心动图检查,比较各组心脏结构改变情况、左室功能。结果:各组心脏结构改变、左室舒张功能受损比较差异无统计学意义(P>0.05);A,B,C,D组左室收缩功能受损与非肥胖组比较差异均有统计学意义(P<0.05)。结论:治疗高血压、糖尿病、高血脂同时应重视肥胖干预。
Objective: To observe the cardiac structure and cardiac function in patients with metabolic syndrome. Methods: According to body mass index, 332 patients with metabolic syndrome were divided into non-obese group (37 cases) and obesity group (295 cases). The obesity group was divided into 4 groups according to the complication. Group A (108 cases) suffered from hypertension, hyperlipidemia, In diabetic group B, 106 patients with hypertension and hyperlipidemia at the same time, and 47 patients with high blood lipid and diabetes at the same time in group C; 34 patients in group D were both diabetic and hypertensive at the same time. Patients underwent echocardiography to compare changes in cardiac structure in each group, left ventricular function. Results: There was no significant difference in the changes of cardiac structure between groups and the impaired left ventricular diastolic function (P> 0.05). The differences of LV systolic dysfunction between groups A, B, C and D were statistically significant Significance (P <0.05). Conclusion: Treatment of hypertension, diabetes, hyperlipidemia should pay attention to obesity intervention.